You are here: Industry Insights > Argentina

News List

Russia says Argentina approves Sputnik Light as standalone and booster vaccine expresspharma
December 07, 2021
Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, but delays in deliveries led the country in August to offer second doses of Moderna and AstraZeneca vaccines to citizens who received the first dose of Russia's ..
Argentina approves Sputnik Light Covid-19 shot as standalone and booster Pharmaceutical-Technology
December 07, 2021
Sputnik Light showed effectiveness as a universal boost when mixed with the vaccines of AstraZeneca, Sinopharm, Moderna and Cansino.
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effecti prnasia
October 15, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light ...
Moderna signs supply pact with Argentina for 20 million doses of its COVID-19 vaccine expresspharma
July 13, 2021
Moderna announced a supply agreement with the government of Argentina for 20 million doses of Moderna’s COVID-19 vaccine or its updated variant booster vaccine candidate, if authorised, to begin delivery in the first quarter of 2022.
COVID-19: US trials for drug made in Taiwan, China Region of China to be expanded firstwordpharma
June 07, 2021
Golden Biotechnology said its drug candidate antroquinonol will enter Phase II trials in the US for treatment of severely ill COVID-19, pending authorisation by the authorities, in the third quarter, as reported Taipei Times.
Argentina registers Russia’s Covid-19 vaccine Sputnik V pharmaceutical-technology
December 25, 2020
The Russian Direct Investment Fund (RDIF) has announced that the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) has registered the Sputnik V vaccine against Covid-19.
Argentina and Mexico to make AstraZeneca COVID-19 vaccine for Latin America expresspharma
August 14, 2020
The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the vaccine for all of Latin America except Brazil.
USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report pharmafile
November 20, 2018
A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with long-term commitments to public investment
Argentina's Sinergium turns to cell-based technology for new vaccine production fiercepharma
April 11, 2017
Argentina's Sinergium Biotech, which is in a consortium to develop a Zika virus vaccine, intends to build a new plant that will use cell biology that can be utilized for a Zika vaccine or for the flu vaccine production it already does.